Blog Read the latest perspectives from our team of subject matter experts and others Industry-Leading H1 Support ServicesH1 offers sponsors unparalleled industry leading support services. The H1 Customer Success team stays embedded with sponsors long after they go live, helping partners realize value quickly, even if users… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Drug DevelopmentIndustry-Leading H1 Support ServicesH1 offers sponsors unparalleled industry leading support services. The H1 Customer Success team stays embedded with sponsors long after they go live, helping partners realize value quickly, even if users… Continue reading → Read the articleyes Drug DevelopmentAI in Clinical TrialsAt Fierce JPM Week 2026, Ariel Katz, CEO and Co-founder of H1, sat down with Paul Bridges, PhD, President of Parexel’s Consulting organization, for a fireside chat that cut… Continue reading → Read the articleno Artificial IntelligenceDrug DevelopmentDrug Development Predictions 2026The drug development landscape is undergoing rapid transformation. After a year of significant policy changes, regulatory updates, and technology maturation, 2026 will be a defining year for how clinical… Continue reading → Read the articleno Artificial IntelligenceProvider DataHealthcare Predictions 2026: Market Shifts That Will Define the IndustryFor 2026, we predict four significant developments in healthcare: provider data regulations will require new compliance standards, health plans will make consumer experience a top strategic priority to win new… Continue reading → Read the articleno Drug DevelopmentUnlocking Smarter Clinical Trial Feasibility with Connected DataWhen it comes to clinical trial feasibility, the stakes are high. Choosing the wrong sites or drafting a protocol without full visibility into patient populations can lead to costly… Continue reading → Read the articleno KOL EngagementFrom Fragmented to Connected: Unlocking the Power of 360° HCP EngagementAt Fierce Pharma Week 2025, Stacey Rivkin took the stage to address one of pharma’s most persistent challenges: despite having more data than ever before, medical and commercial teams still… Continue reading → Read the articleno1234›»
